“HPR, a preclinical CRO based in Japan, specializing in pharmacological evaluation of novel therapeutics in nonhuman primate disease models, announces operation of its own 1.5T GE Healthcare MRI beginning this month, March 2021. The MRI would be completely managed and operated by HPR, thereby increasing access to in vivo imaging for HPR nonhuman primate studies. […]
Read More